Anumana and Novartis partner for AI-based heart disease detection

Related Articles
Philips Launches ECG-AI Marketplace to Enhance Early Cardiac Diagnosis
Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystemJuly 17, 2025
Anumana Named to Fast Company’s 2024 Next Big Things in Tech Awards
Award recognizes Anumana’s innovative AI-driven cardiovascular disease detection technologyNovember 19, 2024
Mayo Clinic platform aids clinical decisions
IMC Newsdesk: Mayo Clinic has developed health technology to deliver clinical decision support tools, diagnostic insights and care recommendations so clinicians can make faster and more accurate diagnoses and provide…April 19, 2021
Anumana Joins the American College of Cardiology to Advance AI-Powered Solutions for Detecting Heart Failure
Anumana’s joins ACC to advance AI solutions for detecting heart failureDecember 12, 2024


